https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Drug-Eluting Stents

Showing all 2 results

Coronary Stent Market Size, Share, Trends Analysis | Global | 2023 – 2029 | MedCore | Segmented by: Type (Bare-Metal Stents, Drug-Eluting Stents)

The global coronary stents market size is estimated to increase over the forecast period to reach a value of more than $4.8 billion in 2029.  The majority of the global coronary stents market share was controlled by Boston Scientific, Medtronic and Abbott. Overall, this global market research includes an analysis of coronary stents companies spawning across more

more...

Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Europe | 2023-2029 | MedSuite | Includes: Coronary Stents, Coronary Balloon Catheters, Coronary Guidewires, and 9 more

The full report suite on the European market for interventional cardiology device includes coronary stents, coronary balloon catheters, coronary catheters, coronary guidewires, coronary embolic protection devices (EPD), atherectomy and intravascular lithotripsy (IVL) devices, coronary chronic total occlusion (CTO) guidewires, coronary introducer sheaths, coronary vascular closure devices (VCD), diagnostic catheter and guidewires, intravascular ultrasound (IVUS) catheters and optical coherence topography (OCT) catheters.

more...